Sanofi blueprints major vaccine production expansion

Sanofi Pasteur has blueprinted plans for a major new vaccine facility in Neuville-sur-Saône, Rhône, France, where the new vaccine against the dengue fever is already planned to be produced. This plant will become the group's third largest European center fully dedicated to vaccines by 2014. Report

Suggested Articles

With a new £131 million contribution from the U.K. government, VMIC aims to both speed up and expand on its prior ambitions.

AstraZeneca scored a $1 billion contribution from the United States for development, production and delivery of its potential COVID-19 vaccine.

AZ is among the companies leading the COVID-19 vaccine race, and after agreeing first to supply the U.K., it's now in talks for delivery worldwide.